Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03892798 · ClinicalTrials.gov registry record
Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene
A clinical trial of Autism Spectrum Disorder and Seizures, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT03892798: Completed study of Autism Spectrum Disorder and Seizures, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03892798 is a study of Autism Spectrum Disorder and Seizures that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 34 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03892798, a study of Autism Spectrum Disorder and Seizures, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol serves as a data collection tool for individuals with variants (missense, nonsense, frameshifts) in the IRF2BPL gene (MIM 611720), which causes Neurodevelopmental Regression, Seizures, Autism and Developmental Delay (NEDAMSS, MIM 618088) and may be involved in other neurodevelopmental presentations. This information will be analyzed to develop a better understanding of the findings and progression of symptoms in individuals with variants in the IRF2BPL gene.
Primary Outcome
The investigators will collect information regarding age at development of symptoms, age at diagnosis, method for diagnosis, specific mutations detected, additional complications with age at onset and treatment.
Conditions Studied
Interventions
- OTHER No interventions are planned
Study Locations (1)
Ohio
- Cincinnati Children's - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2024-05-17 |
What the finished NCT03892798 record still lists
NCT03892798 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (75% lower).
The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which No interventions are planned is the first listed.
NCT03892798 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03892798 about?
NCT03892798 is a clinical study titled "Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene". This protocol serves as a data collection tool for individuals with variants (missense, nonsense, frameshifts) in the IRF2BPL gene (MIM 611720), which causes Neurodevelopmental Regression, Seizures, Autism and Developmental Delay (NEDAMSS, MIM 618088) and may be involved in other neurodevelopmental ...
What is the current status of trial NCT03892798?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2018-11-27. Estimated completion is 2024-05-17.
What conditions does trial NCT03892798 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Seizures, Dystonia, Movement Disorders, NEDAMSS.
What interventions are being tested in trial NCT03892798?
The interventions under investigation include: No interventions are planned (OTHER).
Who is sponsoring clinical trial NCT03892798?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03892798 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03892798's enrollment target sits among peer trials
34 168th of 224 higher than 57 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI